Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
Antipsychotic, Apotex, Armitage, Axid, boxed, CATIE, Circuit, communicating, confidential, Dau, delivery, depreciated, earliest, Eli, ELSI, escrow, extend, extendible, faster, finance, gain, gathering, glucose, indirect, inquiry, Intervention, irrelevant, joined, label, lipid, master, mature, maturity, Mental, metabolism, monthly, National, Novopharm, omitted, Ortiz, parent, pen, pharmacy, responding, restitution, retirement, Robert, schizophrenia, showed, significantly, statistically, study, subsidiary, suicidal, superior, system, Tringali, uncommon, unconditionally, violative, working
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 the Eli Lilly and Company Bonus Plan, As Amended
- 10.2 Master Settlement Agreement
- 11 Statement Re: Computation of Earnings (Loss) Per Share
- 12 Statement Re: Computation of Ratio of Earnings
- 31.1 Rule 13A-14(A) Certification of Sidney Taurel
- 31.2 Rule 13A-14(A) Certification of Charles E. Golden
- 32 Section 1350 Certification
- 99 Cautionary Statement
Related press release
LLY similar filings
Filing view
External links
EXHIBIT 32. Section 1350 Certification
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Eli Lilly and Company, an Indiana corporation (the “Company”), does hereby certify that, to the best of their knowledge:
The Quarterly Report on Form 10-Q for the quarter ended September 30, 2005 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in theForm 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date | November 2, 2005 | /s/ Sidney Taurel | |||
Sidney Taurel | |||||
Chairman of the Board and | |||||
Chief Executive Officer | |||||
Date | November 2, 2005 | /s/ Charles E. Golden | |||
Charles E. Golden | |||||
Executive Vice President and | |||||
Chief Financial Officer |